UKRI announcement: New £14 million investment targets rare diseases
The UK Rare Disease Research Platform has been established with a £14 million investment over five years by the Medical Research Council (MRC) and the National Institute for Health and Care Research (NIHR).
It is made up of a central coordination and administrative hub and 11 specialist nodes based at universities across the UK.
The aim of the platform is to bring together expertise from across the UK rare disease research system to foster new and innovative treatments for those directly and indirectly impacted by rare conditions.
Professor John Iredale, MRC Executive Chair said:
"The UK has great strengths in rare disease research. However, that very rarity means it can be difficult to bring the right people, technologies and tools together to develop effective approaches.
Although these diseases are diverse and have different causes, they often bring common challenges for research into disease mechanisms, diagnosis, management and treatment.
The platform will bring people together, link participants to resources and activities in the UK and internationally, and support projects that deliver advances in rare disease research."
For more information, see link below.
https://www.ukri.org/news/new-14-million-investment-targets-rare-diseases/